Abstract
Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder.
Original language | English |
---|---|
Journal | Dermatology Online Journal |
Volume | 20 |
Issue number | 8 |
Publication status | Published - 2014 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Dermatology